Gilead preclinical data

GILD published data from monkeys infected with SIV, showing that the nucleotide analog protected against infection when given either before or after exposure to the virus.

As reported in Science, one daily dose (30 mg/kg subcutaneously in 20 monkeys; 20 mg/kg in 5 monkeys) for four weeks gave complete protection from any signs of infection for up to one year, the duration of the study. ...